|Articles|September 7, 2021
A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial
Brad Hertz is a BRCA2 previvor who enrolled himself in a clinical trial for prostate cancer.
Advertisement
Clinical trials and research studies are how we move science and research forward. During Prostate Cancer Awareness Month we honor all those with, or at risk for, prostate cancer and we share this story of Brad Hertz, BRCA2 previvor who enrolled himself in a prostate cancer clinical trial at the National Institutes of Health.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
New Combination Treatment Approach Studied in Pancreatic Cancer
3
KTX-1001 Elicits Responses in Some With Multiple Myeloma
4
Biomarker-Free Relacorilant Combo Broadens Options in Ovarian Cancer
5
